MPV (low-dose bortezomib/melphalan/prednisone)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MPV (low-dose bortezomib/melphalan/prednisone), covering 2020-01-18 to 2020-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma [Phase 4]